3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Thrombocytopenia
14
Leukemia, Myeloid, Acute
5
Leukemia
3
Jacobs syndrome
3
Myelodysplastic Syndromes
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Sarcoma
1
Recurrence
1
Purpura, Thrombocytopenic, Idiopathic
1
Primary Myelofibrosis
1
Pathologic Complete Response
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Chemotherapy-induced Thrombocytopenia
1
Blast Crisis
1
Anemia, Refractory, with Excess of Blasts
1
Anemia
1
Interventions
Tretinoin
2
eltrombopag
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
eltrombopag
×
Classical hematology
×
Clear all
NCT01656252
2020-11-03
PrE0901
PrECOG, LLC.
Phase 1/2
Terminated
15 enrolled
5 charts